Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT02514356 |
Date of registration:
|
30/07/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
SMS as an Incentive To Adhere (SITA) - An Intervention Communicating Social Norms by SMS to Improve ARV Adherence
SITA |
Scientific title:
|
A Small Randomized Controlled Trial Providing Weekly Information by SMS About Own and Group-level ARV Adherence to Patients in Two Clinics in Uganda |
Date of first enrolment:
|
August 2015 |
Target sample size:
|
147 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02514356 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Uganda
| | | | | | | |
Contacts
|
Name:
|
Sebastian Linnemayr, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
RAND |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- have been in HIV care at the clinic for at least three months
- are currently taking HIV-related medication (ART or co-trimoxazole)
- either own a phone or have regular access to one
- intend to stay at the clinic for the study period
- are not in boarding school (where phones are forbidden)
Exclusion Criteria:
- does not speak or understand either English or Luganda
- does not have the cognitive capacity to consent and/or understand the study procedures
Age minimum:
15 Years
Age maximum:
24 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Human Immunodeficiency Virus
|
Intervention(s)
|
Behavioral: Own and group level adherence
|
Behavioral: Own adherence
|
Primary Outcome(s)
|
Medication adherence rates using electronically monitored adherence (wise pill) data
[Time Frame: 9 months after enrollment]
|
Secondary Outcome(s)
|
Self-reported adherence
[Time Frame: 9 months after enrollment]
|
Secondary ID(s)
|
1R21MH107218-01
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|